4594 — BrightPath Biotherapeutics Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for BrightPath Biotherapeutics Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3,265	2,305	1,531	1,057	810
Net Total Accounts Receivable
Net Total Receivables	0.283	16.6	0.055	0.006	64.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,651	2,696	1,651	1,181	1,071
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	48.2	24.9	0	0	0
Net Intangible Assets
Other Long Term Assets
Total Assets	3,749	2,771	1,701	1,230	1,121
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	156	185	76.6	191	132
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	212	240	134	251	196
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	3,538	2,531	1,568	979	925
Total Liabilities & Shareholders' Equity	3,749	2,771	1,701	1,230	1,121
Total Common Shares Outstanding